Brevan Howard Capital Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,031
Closed -$215K 2570
2026
Q1
$215K Sell
15,031
-35,498
-70% -$431K ﹤0.01% 1852
2025
Q4
$499K Buy
+50,529
New +$488K 0.01% 1109
2025
Q2
Sell
-22,836
Closed -$213K 2008
2025
Q1
$213K Buy
+22,836
New +$235K ﹤0.01% 961
2024
Q4
Sell
-23,236
Closed -$302K 1415
2024
Q3
$302K Buy
23,236
+6,799
+41% +$98.2K ﹤0.01% 858
2024
Q2
$236K Buy
16,437
+3,589
+28% +$58.9K ﹤0.01% 848
2024
Q1
$223K Buy
+12,848
New +$185K ﹤0.01% 760

Other funds holding SWBI

Brevan Howard Capital Management's SWBI Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Smith & Wesson (SWBI) in Q2 2026, closing a stake of 15,031 shares — an estimated $215K sold.

Brevan Howard Capital Management first reported a position in SWBI in Q1 2024 and held it in 6 quarters. The position peaked at $499K in Q4 2025. 199 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Smith & Wesson position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 15,031 Smith & Wesson shares in Q2 2026, an estimated $215K.
  • Brevan Howard Capital Management first reported a position in Smith & Wesson in Q1 2024 and held it in 6 quarters.
  • Brevan Howard Capital Management's Smith & Wesson position peaked at $499K in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.